Prostate Anatomy & Histology: Complete Guide for Clinicians
- Gross anatomy – location, size, shape, capsule
- Zonal anatomy – peripheral, central, transitional zones
- Clinical significance of zones – BPH vs. cancer
- Histology – glandular epithelium and stroma
- Blood supply – arteries, veins, Batson's plexus
- Innervation – neurovascular bundles, sympathetic and parasympathetic
- Lymphatic drainage – obturator, internal iliac, presacral nodes
- Embryology – development from urogenital sinus
- Age-related changes – growth patterns, BPH
- Interactive FAQ – 9 questions about prostate anatomy and histology
Gross anatomy – location, size, shape, capsule
The prostate is a fibromuscular glandular organ located in the male pelvis, inferior to the bladder and posterior to the pubic symphysis. It surrounds the prostatic urethra.
- Shape: Inverted cone or chestnut-shaped.
- Dimensions: Base: 3-4 cm (width) × 2-3 cm (height). Apex: 2-3 cm (width). Length (base to apex): 3-4 cm.
- Weight: 15-20 g in young adults; increases with age (BPH).
- Capsule: The prostate is surrounded by a fibromuscular capsule (false capsule) that condenses from the periprostatic fascia. This capsule is clinically important for surgical planes during radical prostatectomy.
- Relations:
- Anterior: Pubic symphysis (retropubic space of Retzius)
- Posterior: Rectum (separated by Denonvilliers' fascia)
- Superior: Bladder neck
- Inferior: Urogenital diaphragm and external urethral sphincter
- Lateral: Levator ani muscles and neurovascular bundles
Zonal anatomy – peripheral, central, transitional zones
The zonal anatomy of the prostate, described by McNeal in 1968, is essential for understanding disease distribution.
- Peripheral zone (PZ) – 70% of glandular tissue:
- Location: Posterior and lateral aspects of the prostate
- Ducts empty into the distal prostatic urethra
- Clinical importance: Site of 70-80% of prostate cancers
- Palpable on digital rectal exam (DRE)
- Central zone (CZ) – 25% of glandular tissue:
- Location: Base of the prostate, surrounding the ejaculatory ducts
- Ducts empty near the verumontanum
- Clinical importance: Uncommon site for cancer (5-10%)
- Transitional zone (TZ) – 5% of glandular tissue:
- Location: Surrounds the proximal prostatic urethra
- Clinical importance: Site of benign prostatic hyperplasia (BPH)
- Rare site for cancer (10-15%), but cancers here are often palpable
- Anterior fibromuscular stroma (AFMS):
- Location: Anterior surface of the prostate
- Non-glandular tissue – smooth muscle and fibrous tissue
- Clinical importance: Can be a site for anterior prostate cancer (5-10%)
Clinical significance of zones – BPH vs. cancer
Understanding zonal anatomy is critical for clinical practice:
- BPH (benign prostatic hyperplasia): Arises in the transitional zone and periurethral glands. This explains why BPH causes urinary obstruction (the TZ surrounds the urethra).
- Prostate cancer: 70-80% arise in the peripheral zone. This explains why many prostate cancers are palpable on DRE (the PZ is posterior, adjacent to the rectum).
- Anterior prostate cancer: 5-10% arise in the anterior fibromuscular stroma or anterior transitional zone. These are not palpable on DRE and may be missed on standard biopsy templates (requires anterior sampling or MRI-targeted biopsy).
- Transitional zone cancer: 10-15% arise in the TZ. These may be less aggressive and often have lower Gleason scores.
Histology – glandular epithelium and stroma
The prostate is a tubuloalveolar gland composed of epithelial and stromal components.
Epithelial cells:
- Basal cells: Thin layer of cuboidal cells at the base of the epithelium. Express high-molecular-weight cytokeratins (34βE12, CK5/6). Loss of basal cells is a hallmark of prostate cancer (used in immunohistochemistry).
- Secretory (luminal) cells: Tall columnar cells that produce prostatic fluid, including PSA (prostate-specific antigen) and PAP (prostatic acid phosphatase). Express androgen receptors.
- Neuroendocrine cells: Scattered cells that produce chromogranin A, serotonin, and calcitonin. Rarely form pure neuroendocrine tumours (small cell carcinoma of the prostate).
Stroma:
- Smooth muscle cells (contractile function)
- Fibroblasts
- Extracellular matrix (collagen, elastin)
- Blood vessels and nerves
Immunohistochemistry in diagnosis:
- Basal cell markers (positive in benign glands): 34βE12 (high-molecular-weight cytokeratin), p63, CK5/6
- Loss of basal cells: Suggests prostate cancer
- AMACR (racemase): Overexpressed in prostate cancer (positive in malignant glands)
Blood supply – arteries, veins, Batson's plexus
Arterial supply:
- Main supply: Inferior vesical artery (branch of the internal iliac artery)
- Prostatic arteries: Arise from the inferior vesical artery and enter the prostate at the posterolateral border
- Accessory supply: Middle rectal artery, internal pudendal artery (minor contributions)
Venous drainage:
- Prostatic venous plexus (Santorini's plexus): Surrounds the prostate and bladder neck
- Drains into: Internal iliac veins
- Batson's plexus (vertebral venous plexus): Communication between the prostatic venous plexus and the vertebral veins. This provides a route for prostate cancer metastasis to the spine without passing through the lungs.
Innervation – neurovascular bundles, sympathetic and parasympathetic
Parasympathetic (erectile function):
- Nerve origin: Pelvic splanchnic nerves (S2-S4)
- Path: Run posterolaterally to the prostate as the neurovascular bundles
- Function: Vasodilation → erection
- Surgical importance: Injury to neurovascular bundles during radical prostatectomy causes erectile dysfunction
Sympathetic (ejaculation):
- Nerve origin: Hypogastric nerves (T10-L2)
- Function: Smooth muscle contraction → ejaculation, bladder neck closure
Somatic:
- Pudendal nerve (S2-S4): Controls the external urethral sphincter and bulbospongiosus muscle
Lymphatic drainage – obturator, internal iliac, presacral nodes
Prostate cancer typically spreads first to regional lymph nodes before distant metastasis.
- Primary drainage: Obturator and internal iliac (hypogastric) lymph nodes
- Secondary drainage: External iliac, presacral, and common iliac nodes
- Lymph node dissection during radical prostatectomy: Obturator and internal iliac nodes are removed for staging
Embryology – development from urogenital sinus
The prostate develops from the urogenital sinus (endoderm) under the influence of androgens (testosterone, DHT).
- Week 10-12: Prostatic buds sprout from the urogenital sinus
- Second trimester: Glandular branching and differentiation
- Birth: Prostate is small and primarily stromal
- Puberty: Androgen surge causes rapid growth and glandular development
Age-related changes – growth patterns, BPH
The prostate grows throughout life, with two phases of growth:
- First growth phase (puberty): Prostate reaches adult size (15-20 g) by age 20-25
- Second growth phase (after age 40): Gradual enlargement due to BPH (transitional zone)
- Histological changes with age:
- Increased stromal component
- Glandular atrophy
- Chronic inflammation (common)
- Corpora amylacea (calcified proteinaceous deposits)
Interactive FAQ – Prostate anatomy and histology
Peripheral zone (70%), central zone (25%), transitional zone (5%), and anterior fibromuscular stroma.
Peripheral zone – 70-80% of prostate cancers arise here.
Transitional zone – BPH arises here, causing urethral compression.
Nerves (pelvic splanchnic) that run posterolateral to the prostate, controlling erections. Preserved during nerve-sparing prostatectomy.
The vertebral venous plexus that communicates with the prostatic venous plexus. Allows prostate cancer to metastasise to the spine without passing through the lungs.
Benign glands: basal cells present (p63+, 34βE12+). Cancer: basal cells absent, AMACR+.
A fascial layer separating the prostate from the rectum. Important surgical plane during radical prostatectomy.
Inferior vesical artery (branch of internal iliac artery).
Obturator and internal iliac (hypogastric) lymph nodes – first echelon.
Disclaimer: This information is for educational purposes and intended for clinicians and medical students. It is not a substitute for clinical judgment or primary literature.